HK1034184A1 - Peroral active agent suspension. - Google Patents

Peroral active agent suspension.

Info

Publication number
HK1034184A1
HK1034184A1 HK01104589A HK01104589A HK1034184A1 HK 1034184 A1 HK1034184 A1 HK 1034184A1 HK 01104589 A HK01104589 A HK 01104589A HK 01104589 A HK01104589 A HK 01104589A HK 1034184 A1 HK1034184 A1 HK 1034184A1
Authority
HK
Hong Kong
Prior art keywords
active agent
agent suspension
peroral
peroral active
suspension
Prior art date
Application number
HK01104589A
Inventor
Dietrich Turck
Veit Schmelmer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HK1034184A1 publication Critical patent/HK1034184A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
HK01104589A 1998-03-27 2001-07-04 Peroral active agent suspension. HK1034184A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (en) 1998-03-27 1998-03-27 Peroral drug suspension
EP9949845 1999-10-07

Publications (1)

Publication Number Publication Date
HK1034184A1 true HK1034184A1 (en) 2001-10-19

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104589A HK1034184A1 (en) 1998-03-27 2001-07-04 Peroral active agent suspension.

Country Status (26)

Country Link
EP (2) EP0945131A1 (en)
JP (1) JP3323189B2 (en)
KR (1) KR100587208B1 (en)
CN (1) CN1150888C (en)
AR (1) AR016196A1 (en)
AT (1) ATE225648T1 (en)
AU (1) AU762464B2 (en)
BR (1) BR9909189A (en)
CA (1) CA2326048C (en)
CO (1) CO5070601A1 (en)
DE (1) DE59903023D1 (en)
DK (1) DK1066029T3 (en)
ES (1) ES2184428T3 (en)
HK (1) HK1034184A1 (en)
HU (1) HU228474B1 (en)
IL (1) IL137479A (en)
MY (1) MY124599A (en)
NO (1) NO321401B1 (en)
NZ (1) NZ507610A (en)
PL (1) PL192969B1 (en)
PT (1) PT1066029E (en)
TR (1) TR200002772T2 (en)
TW (1) TWI232759B (en)
UY (1) UY25443A1 (en)
WO (1) WO1999049845A1 (en)
ZA (1) ZA200003951B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US20070042006A1 (en) * 2003-04-07 2007-02-22 Lau Kai K Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
DE602005009016D1 (en) * 2004-12-06 2008-09-25 Janssen Pharmaceutica Nv ORAL SUSPENSION WITH MELOXICAM
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
CA2777366C (en) * 2009-10-12 2023-11-14 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
CA2800235C (en) * 2010-03-10 2018-10-16 Lupin Limited Rifaximin ready-to-use suspension
RU2015142279A (en) * 2010-03-19 2018-12-28 Бостон Байомедикал, Инк. NEW COMPOUNDS AND COMPOSITIONS FOR TARGETING MALIGNANT STEM CELLS
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
CN104854411B (en) * 2012-12-19 2017-06-13 三菱电机株式会社 Air conditioner
RU2749423C2 (en) 2015-04-28 2021-06-10 Марс, Инкорпорейтед Method for producing sterilized wet feed product for pets
KR102145022B1 (en) * 2018-08-14 2020-08-14 동아제약 주식회사 Suspension composition and dosage form of ibuprofen
CN112044605B (en) * 2019-06-06 2022-06-21 钟志勇 Titanium selection medicament and titanium selection method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (en) * 1984-10-22 1988-11-16 Chiesi Farma Spa AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (en) * 1992-03-10 1999-02-24 エスエス製薬株式会社 Planoprofen suspension syrup
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
NO20004822L (en) 2000-11-23
EP1066029B1 (en) 2002-10-09
JP3323189B2 (en) 2002-09-09
MY124599A (en) 2006-06-30
DK1066029T3 (en) 2003-01-27
KR100587208B1 (en) 2006-06-08
AU3147099A (en) 1999-10-18
JP2002509875A (en) 2002-04-02
CN1295462A (en) 2001-05-16
PL192969B1 (en) 2006-12-29
WO1999049845A1 (en) 1999-10-07
HUP0102036A2 (en) 2002-03-28
TR200002772T2 (en) 2000-12-21
HU228474B1 (en) 2013-03-28
PL342345A1 (en) 2001-06-04
TWI232759B (en) 2005-05-21
NO321401B1 (en) 2006-05-08
ES2184428T3 (en) 2003-04-01
KR20010042197A (en) 2001-05-25
BR9909189A (en) 2000-12-05
HUP0102036A3 (en) 2002-12-28
CA2326048C (en) 2008-08-12
AR016196A1 (en) 2001-06-20
AU762464B2 (en) 2003-06-26
ZA200003951B (en) 2002-01-18
IL137479A0 (en) 2001-07-24
IL137479A (en) 2005-09-25
DE59903023D1 (en) 2002-11-14
NO20004822D0 (en) 2000-09-26
ATE225648T1 (en) 2002-10-15
CO5070601A1 (en) 2001-08-28
PT1066029E (en) 2003-02-28
CN1150888C (en) 2004-05-26
EP1066029A1 (en) 2001-01-10
CA2326048A1 (en) 1999-10-07
NZ507610A (en) 2003-08-29
EP0945131A1 (en) 1999-09-29
UY25443A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
ZA200003951B (en) Peroral active agent suspension.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
MXPA01013362A (en) ANTI-alphav.
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA99254B (en) Benzosulfone derivatives.
ZA200001665B (en) Suspension device.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
HK1027141A1 (en) Beam supporter.
HK1046366A1 (en) Ziprasidone suspension.
ZA200204863B (en) Suspension comprising oxcarbazepine.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA99473B (en) New naphthyl- and anilide-substituted sulphonamides.
ZA99733B (en) Ophthalmic composition.
ZA991550B (en) Cyclohexanediole derivatives.
ZA9810637B (en) Formulations comprising dissolved paroxetine.
ZA993123B (en) Trisresorcinyltriazines.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
GB9709948D0 (en) W.C.cistern
HK1046532A1 (en) Phenyl-and pyridyl-tetrahydro-pyridines having tnfinhibiting activity.
ZA986160B (en) 2,4,4-trisubstituted-1,3-dioxolone antifungals.
ZA991761B (en) New agent.
ZA991336B (en) Odoriferous agent.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20190322